安瑞医疗器械有限公司(“安瑞医疗”)欣然宣布，康桥资本已投资2500万美元完成了对安瑞医疗重组并成为控股股东。

安瑞医疗是微创医疗器械领域的设计及生产专家。自2006年成立以来，安瑞医疗一直致力于消化道微创外科器械的研发、生产与销售，在业界建立了良好的品牌形象和声誉，其产品获得欧盟CE认证和中国CFDA的注册，在中国有成熟的销售网络和广泛的市场覆盖，并大规模出口到欧洲、东南亚、美洲等海外市场。

在完成对安瑞医疗的控股后，康桥资本的傅唯先生和丁伟先生将加入公司董事会，康桥资本的潘要干先生将出任公司CEO。潘先生曾任外科医生，有超过十五年在跨国医疗器械公司的管理经验。与此同时，曾任美敦力和卡尔斯托斯运营高管的许崇刚先生以及曾任奥林巴斯和科医人销售高管的高嵩先生也将加入公司，他们将与安瑞医疗现有管理团队一同带领安瑞医疗迈向新的征程。

康桥资本董事总经理丁伟先生表示：“安瑞医疗在业内深耕十年，拥有卓越的研发能力、精湛的生产工艺和良好的客户口碑。本次交易完成以后，康桥资本与创始人刘雅茹女士将携手推动公司加速发展，安瑞医疗将成为国产医疗器械高值耗材的并购整合平台，加速实现医疗器械国产化和进口替代，更经济更优质地服务于中国患者。

关于康桥资本

康桥资本是一个专注于医疗健康产业投资的私募基金，主要从事中、晚期成长型和并购型投资，涵盖生物制药、药品流通、分子诊断、医疗器械和医疗服务等多个医疗健康细分领域。截止目前，康桥资本所管理的资产规模已超过7亿美元。

康桥资本旨在通过运用资本的力量，加速现代医疗、医药技术的研发和市场化，以提高全民医疗健康水平，造福人类。

Anrei Medical Device Co., Ltd. (“Anrei Medical”) announced today that C-Bridge Capital has invested US$25 million to acquire the controlling stake over Anrei Medical.

Anrei Medical is a design & manufacturing expert in minimally invasive medical devices. Since its foundation in 2006, Anrei Medical has focused itself on developing, manufacturing and commercializing endoscopic surgical devices, and now is a strong brand in the sector. Anrei Medical has a full spectrum of product lines with CFDA and CE registrations, a mature sales network with deep coverage in China and significant exports to overseas markets such as Europe, Southeast Asia and America.

Upon the acquisition of Anrei Medical, Mr. Wei Fu and Mr. Wei Ding from C-Bridge will join its board of directors. Mr. Rhett Pan, also from C-Bridge, will serve as its CEO. Rhett brings more than 15 years of industry experiences including being a general surgeon and corporate executive in several multinational medical device companies. Mr. Steve Xu, formerly a senior executive of Medtronic and Karl Storz, as well as Mr. Song Gao, formerly a senior sales director of Olympus and sales VP of Lumenis, will join Anrei Medical. 　They will work with Anrei Medical’s existing management team to lead Anrei Medical for its new journey.

“The core assets of Anrei Medical are its development capability, manufacture quality and strong reputation among its customers. We are thrilled to partner with Ms. Yaru Liu, founder of Anrei Medical, to further promote Anrei Medical. We trust that Anrei Medical will become a premier medical device platform in China at the direction of its enhanced management team", commented on the deal Mr. Wei Ding, Partner of C-Bridge Capital, “Anrei Medical will strive to help acceleration of localization and import substitution in medical device industry and better serve Chinese patients in an economic and timely manner.”

About C-Bridge Capital

C-Bridge Capital is a healthcare dedicated private equity firm, focused on growth and late stage investment opportunities. C-Bridge Capital’s current portfolio includes China’s leading players in pharmaceuticals, medical devices, diagnosis and healthcare services. As of today, the AUM of C-Bridge Capital has exceeded US$700 million.

With the power of capital market, C-Bridge Capital is committed to support commercialization of cutting edge technologies and companies that fulfill unmet medical needs, thus continuously improving the standard and quality of care for patients. 　(编辑：安彩月)